The first steps

  • Intensive R&D at the University Hospital of Vienna with the focus on quick and mobile cooling afterCardiac Arrest 

  • First design of EMCOOLS Pads 


The company

  • EMCOOLS - Emergency Medical Cooling Systems AG is founded 

  • Venture capital financing

  • First sales in Austria, Germany and Switzerland 

  • Continuous R&D and transfer to a new modern production site 

  • First CE certification based on EN ISO 13485

  • FDA-approval for the US market 

  • Launch of EMCOOLS Brain.PadTM for neck and shoulder cooling

2011 - 2014

Market extension

  • Further indications approved: stroke and myocardial infarction

  • Product registration in China, Taiwan, South Korea and Japan
  • EMCOOLS – Emergency Medical Cooling Systems AG is renamed in EMCOOLS Medical Cooling Systems AG 

  • Besides emergency medicine, the company focus shifts to the use of EMCOOLS HypoCarbon® Pads in critically ill patients 

  • EMCOOLS Corp. founded as a 100% US-subsidiary


Status quo

  • Further indications and products approved

  • Distribution in more than 25 countries

  • More than 10 international product registrations outside of Europe

  • Worldwide more than 20.000 patients treated with HypoCarbon® Pads

  • Patents: Hypocarbon® Pads are patented in Europa, the US and other key markets  

Back to Top